Re-entry into the cell cycle: A mechanism for neurodegeneration in Alzheimer disease

Medical Hypotheses

Volumn 52, Issue 6, 1999, Pages 525-527

  McShea, A ^a   Wahl, A F ^a   Smith, M A ^b  

^a BRISTOL MYERS SQUIBB   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; PROTEIN;

ALZHEIMER DISEASE; CELL CYCLE; CELL DIVISION; GROWTH; HUMAN; MITOSIS; NERVE DEGENERATION; NEUROFILAMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SHORT SURVEY;

EID: 0033037948     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1054/mehy.1997.0680     Document Type: Article

References (31)

1. Arendt T., Holzer M., Grossmann A., Zedlick D., Bruckner M. K. Increased expression and subcellular translocation of the mitogen activated protein kinase and mitogen-activated protein kinase in Alzheimer''s disease. Neuroscience. 68:1995;5-18.
2. Arendt T., Rodel L., Gartner U., Holzer M. Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease. Neuroreport. 7:1996;3047-3049.
3. McShea A., Harris P. L. R., Webster K. R., Wahl A. F., Smith M. A. Abnormal expression of the cell cycle regulators p16 and CDK4 in Alzheimer's disease. Am J Pathol. 150:1997;1933-1339.
4. Smith T. W., Lippa C. F. Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disorders. J Neuropathol Exp Neurol. 54:1995;297-303.
5. Vincent I., Rosado M., Davies P. Mitotic mechanisms in Alzheimer's disease. J Cell Biol. 132:1996;413-425.
6. Trojanowski J. Q., Schmidt M. L., Shin R. W., Bramblett G. T., Goedert M., Lee V. M.-Y. PHFτ (A68): from pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin Neurosci. 1:1993;184-191.
7. Brion J. P., Passarier H., Nunez J., Flament-Durand J. Immunologic determinants of tau protein are present in neurofibrillary tangles of Alzheimer's disease. Arch Biol. 95:1985;229-235.
8. Brion J. P., Octave J. N., Couck A. M. Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience. 63:1994;895-909.
9. Grundke-Iqbal I., Iqbal K., Tung Y. C., Quinlan M., Wisniewski H. M., Binder L. I. Abnormal phosphorylation of the microtubule-associated protein tau in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA. 83:1986;4913-4917.
10. Kanemaru K., Takio K., Miura R., Titani K., Ihara Y. Fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem. 58:1992;1667-1675.
11. 396in Alzheimer's disease recapitulates development and contributes to reduced microtubule bindings. Neuron. 10:1993;1089-1099.
12. Goedert M., Jakes R., Growther R. A. The abnormal phosphorylation of tau protein at serine-202 in Alzheimer disease recapitulates phosphorylation during development. Proc Natl Acad Sci USA. 90:1993;5066-5070.
13. Lee J. H., Goedert M., Hill W. D., Lee V. M.-Y., Trojanowski J. Q. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol. 121:1993;93-105.
14. Pope W., Enam S. A., Bawa N., Miller B. E., Ghanbari H. A., Klein W. L. Phosphorylated tau epitopes of Alzheimer's disease is coupled to axon development in the avian central nervous system. Exp Neurol. 120:1993;106-113.
15. Pope W. B., Lambert M. P., Leypold B. Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y. Exp Neurol. 126:1994;185-194.
16. Preuss U., Doring F., Illenberger S., Mandelkow E. M. Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells. Mol Biol Cell. 6:1995;1397-1410.
17. Ledesma M. D., Correas I., Avila J., Diaz-Nido J. Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's disease. FEBS Lett. 308:1992;218-224.
18. Baumann K., Mandelkow E. M., Biernat J., Piwnica-Worms H., Mandelkow E. Abnormal Alzheimer-like phosphorylation of tau-protein by cyclin-dependent kinases cdk2 and cdk5. FEBS Lett. 336:1993;417-424.
19. Liu W.-K., Williams R. T., Hall F. L., Dickson D. W., Yen S.-H. Detection of a Cdc2-related kinase associated with Alzheimer paired helical filaments. Am J Pathol. 146:1995;228-238.
20. Yamaguchi H., Ishiguro K., Uchida T., Takashima A., Lemere C. A., Imahori K. Preferential labeling of Alzheimer neurofibrillary tangles with antisera for tau protein kinase (TPK) I/glycogen synthase kinase-3β and cyclin-dependent kinase 5, a component of TPK II. Acta Neuropathol. 92:1996;232-241.
21. Wahl A. F., Donaldson K. L., Fairchild C. et al. Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nature Med. 2:1996;72-79.
22. James T. W., Bohman R. Proliferation of mitochondria during the cell cycle of the human cell line (HL-60). J Cell Biol. 89:1981;256-260.
23. Smith M. A., Sayre L. M., Monnier V. M., Perry G. Radical AGEing in Alzheimer's disease. Trends Neurosci. 18:1995;172-176.
24. Smith M. A., Sayre L. M., Perry G. Is Alzheimer's a disease of oxidative stress? Alzheimer's Dis Rev. 1:1996;63-67.
25. Smith M. A., Sayre L. M., Perry G. Morphological aspects of oxidative damage in Alzheimer's diseasee. Beal M. F., Howell N., Bodis-Wollner I. Mitochondria and Free Radicals in Neurodegenerative Diseases. 1997;335-342 Wiley-Liss, New York.
26. Gomez-Pinilla F., Cummings B. J., Cotman C. W. Induction of basic fibroblast growth factor in Alzheimer's disease pathology. Neuroreport. 1:1990;211-214.
27. Stopa E. G., Gonzalez A.-M., Chorsky R. Basic fibroblast growth factor in Alzheimer's disease. Biochem Biophys Res Commun. 171:1990;690-696.
28. Crutcher K. A., Scott S. A., Liang S., Everson W. V., Weingartner J. Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's disease. J Neurosci. 13:1993;2540-2550.
29. van der Wal E. A., Gomez-Pinilla F., Cotman C. W. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport. 4:1993;69-72.
30. Gartner U., Holzer M., Heumann R., Arendt T. Induction of p21ras in Alzheimer pathology. Neuroreport. 6:1995;1441-1444.
31. Serrano M., Lin A. W., McCurrach M. E., Beach D., Lowe S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p161NK4a. Cell. 88:1997;593-602.